Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PROGENICS PHARMACEUTICALS IN Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 119.31 M 130.42 M 125.79 M 166.06 M 30.22 M
    Net Receivables 1.34 M 2.00 M 1.70 M 3.29 M 1.30 M
    Total Inventories 0.00 0.00 0.00 0.00 0.00
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses
    Other Current Assets 3.53 M 3.11 M 3.18 M 2.56 M 1.81 M
    Current Assets Total 124.18 M 135.53 M 130.67 M 171.90 M 33.33 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 371,000.00 0.00
    Other Investments 22.58 M 40.50 M 23.86 M 7.04 M 1.52 M
    Property, Plant & Equipment Net 11.07 M 13.51 M 11.39 M 4.16 M 4.69 M
    Property, Plant & Equipment Gross 27.70 M 25.68 M 20.62 M 11.96 M 11.03 M
    Accumulated Depreciation 16.63 M 12.17 M 9.23 M 7.81 M 6.34 M
    Other Assets 0.00 0.00 0.00 538,000.00 0.00
    Deferred Charges 0.00 0.00 0.00 0.00 0.00
    Tangible Other Assets 538,000.00 535,000.00 532,000.00 131,000.00
    Intangible Other Assets 0.00 0.00 0.00 0.00 0.00
    Total Assets 157.83 M 189.54 M 165.91 M 184.00 M 39.54 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Accrued Payroll 1.09 M 1.49 M 990,000.00 1.14 M 734,000.00
    Income Taxes Payable 0.00 0.00 0.00 201,000.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 36.21 M 29.90 M 36.29 M 32.58 M 5.49 M
    Current Liabilities Total 38.20 M 32.55 M 38.84 M 34.80 M 7.66 M
    Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 9.13 M 16.10 M 36.42 M
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 266,000.00 359,000.00 123,000.00 49,000.00 42,000.00
    Total Liabilities 38.46 M 42.04 M 55.06 M 71.27 M 7.71 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 119.37 M 147.50 M 110.85 M 112.73 M 31.84 M
    Common Stock 40,000.00 39,000.00 34,000.00 33,000.00 22,000.00
    Capital Surplus 422.08 M 401.50 M 321.32 M 306.08 M 153.47 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves -1.30 M 6,000.00 -145,000.00 -4.50 M -2.25 M
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 0.00
    Retained Earnings -298.72 M -254.05 M -210.36 M -188.74 M -119.31 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities -148,000.00 -91,000.00 14,000.00 106,000.00
    Treasury Stock 2.74 M 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 157.83 M 189.54 M 165.91 M 184.00 M 39.54 M
    Common Shares Outstanding 28.07 M 29.75 M 26.20 M 25.23 M 17.28 M